Recombinant adenovirus-mediated p14(ARF) overexpression sensitizes human breast cancer cells to cisplatin (Q40708189)

22 September 2017

Recombinant adenovirus-mediated p14(ARF) overexpression sensitizes human breast cancer cells to cisplatin (English)

1 reference

22 September 2017

1 reference

1 reference

Xiyun Deng

1

1 reference

22 September 2017

Min Kim

2

1 reference

22 September 2017

Didier Vandier

3

1 reference

22 September 2017

Yun-jin Jung

4

1 reference

22 September 2017

Toshiki Rikiyama

5

1 reference

22 September 2017

Magda K Sgagias

6

1 reference

22 September 2017

Merrill Goldsmith

7

1 reference

22 September 2017

Kenneth H Cowan

8

1 reference

22 September 2017

1 August 2002

1 reference

Biochemical and Biophysical Research Communications

22 September 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

22 September 2017

296

1 reference

22 September 2017

4

1 reference

22 September 2017

792-798

1 reference

Role of the INK4a locus in tumor suppression and cell mortality.

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

The INK4a/ARF network in tumour suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

p14ARF links the tumour suppressors RB and p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

The INK4a/ARF locus in murine tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

p53-independent apoptosis is induced by the p19ARF tumor suppressor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Recent trends in breast cancer incidence and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Tumor surveillance via the ARF-p53 pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Caspase-3 is not essential for DNA fragmentation in MCF-7 cells during apoptosis induced by the pyrrolo-1,5-benzoxazepine, PBOX-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Recombinant adenovirus vectors for gene therapy and clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

Cisplatin and its analogues in the treatment of advanced breast cancer: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900948-8

10.1016/S0006-291X(02)00948-8

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference